Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||
Cost of Revenue | |||||||||
Gross Profit | |||||||||
Gross Profit Margin (%) | |||||||||
R&D Expense | |||||||||
SG&A Expense | |||||||||
Total Operating Expenses | |||||||||
Operating Income or Loss | |||||||||
Operating Margin (%) | |||||||||
Interest Expense | |||||||||
Total Other Income/Expenses | |||||||||
Income Before Tax | |||||||||
Income Tax Expense | |||||||||
Income from Continuing Ops. | |||||||||
Net Income | |||||||||
Net Profit Margin (%) | |||||||||
Net Income Available to Common Shareholders | |||||||||
Basic EPS | |||||||||
Diluted EPS | |||||||||
Basic Average Shares | |||||||||
Diluted Average Shares |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||
Cost of Revenue | ||||||||||||||
Gross Profit | ||||||||||||||
Gross Profit Margin (%) | ||||||||||||||
R&D Expense | ||||||||||||||
SG&A Expense | ||||||||||||||
Total Operating Expenses | ||||||||||||||
Operating Income or Loss | ||||||||||||||
Operating Margin (%) | ||||||||||||||
Interest Expense | ||||||||||||||
Total Other Income/Expenses | ||||||||||||||
Income Before Tax | ||||||||||||||
Income Tax Expense | ||||||||||||||
Income from Continuing Ops. | ||||||||||||||
Net Income | ||||||||||||||
Net Profit Margin (%) | ||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||
Basic EPS | ||||||||||||||
Diluted EPS | ||||||||||||||
Basic Average Shares | ||||||||||||||
Diluted Average Shares |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||
Cash & Cash Equivalents | |||||||||
Marketable Securities | |||||||||
Receivables | |||||||||
Inventories | |||||||||
Other Current Assets | |||||||||
Total Current Assets | |||||||||
Non-Current Assets | |||||||||
Marketable Securities | |||||||||
PPE Net | |||||||||
Intangibles inc. Goodwill | |||||||||
Other Non-Current Assets | |||||||||
Total Non-Current Assets | |||||||||
Total Assets | |||||||||
Current Liabilities | |||||||||
Accounts Payable | |||||||||
Deferred Revenues | |||||||||
Debt, Current | |||||||||
Accrued Liabilities | |||||||||
Other Current Liabilities | |||||||||
Total Current Liabilities | |||||||||
Non-Current Liabilities | |||||||||
Deferred Revenues | |||||||||
Debt, Non-Current | |||||||||
Other Non-Current Liabilities | |||||||||
Total Non-Current Liabilities | |||||||||
Total Liabilities | |||||||||
Shareholders' Equity | |||||||||
Common Stock | |||||||||
Additional Paid-In Capital | |||||||||
Retained Earnings | |||||||||
Other Shareholders' Equity | |||||||||
Total Shareholders' Equity | |||||||||
Total Liabilities & Shareholders' Equity |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||
Cash & Cash Equivalents | ||||||||||||||
Marketable Securities | ||||||||||||||
Receivables | ||||||||||||||
Inventories | ||||||||||||||
Other Current Assets | ||||||||||||||
Total Current Assets | ||||||||||||||
Non-Current Assets | ||||||||||||||
Marketable Securities | ||||||||||||||
PPE Net | ||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||
Other Non-Current Assets | ||||||||||||||
Total Non-Current Assets | ||||||||||||||
Total Assets | ||||||||||||||
Current Liabilities | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Current | ||||||||||||||
Accrued Liabilities | ||||||||||||||
Other Current Liabilities | ||||||||||||||
Total Current Liabilities | ||||||||||||||
Non-Current Liabilities | ||||||||||||||
Deferred Revenues | ||||||||||||||
Debt, Non-Current | ||||||||||||||
Other Non-Current Liabilities | ||||||||||||||
Total Non-Current Liabilities | ||||||||||||||
Total Liabilities | ||||||||||||||
Shareholders' Equity | ||||||||||||||
Common Stock | ||||||||||||||
Additional Paid-In Capital | ||||||||||||||
Retained Earnings | ||||||||||||||
Other Shareholders' Equity | ||||||||||||||
Total Shareholders' Equity | ||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Jun 2021 | Mar 2021 | Dec 2020 | ||
---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||
Net Income | |||||||||
Depreciation & Amortization | |||||||||
Deferred Income Taxes | |||||||||
Stock Based Compensation | |||||||||
Accounts Receivable | |||||||||
Inventory | |||||||||
Accounts Payable | |||||||||
Deferred Revenue | |||||||||
Other Non-Cash | |||||||||
Operating Cash Flow | |||||||||
Cash Flows from Investing Activities | |||||||||
PPE Investments | |||||||||
Net Acquisitions | |||||||||
Purchase of Investments | |||||||||
Sale of Investments | |||||||||
Other Investing Activity | |||||||||
Investing Cash Flow | |||||||||
Cash Flows from Financing Activities | |||||||||
Debt Issued | |||||||||
Proceeds from Debt Repayment | |||||||||
Debt Repayment | |||||||||
Proceeds from Sale of Equity | |||||||||
Equity Repurchased | |||||||||
Dividend Paid | |||||||||
Other Financing Activity | |||||||||
Financing Cash Flow | |||||||||
Cash Position | |||||||||
Beginning Cash Position | |||||||||
End Cash Position | |||||||||
Change in Cash | |||||||||
Free Cash Flow | |||||||||
Operating Cash Flow | |||||||||
Capital Expenditure | |||||||||
Free Cash Flow |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||
Net Income | ||||||||||||||
Depreciation & Amortization | ||||||||||||||
Deferred Income Taxes | ||||||||||||||
Stock Based Compensation | ||||||||||||||
Accounts Receivable | ||||||||||||||
Inventory | ||||||||||||||
Accounts Payable | ||||||||||||||
Deferred Revenue | ||||||||||||||
Other Non-Cash | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||
PPE Investments | ||||||||||||||
Net Acquisitions | ||||||||||||||
Purchase of Investments | ||||||||||||||
Sale of Investments | ||||||||||||||
Other Investing Activity | ||||||||||||||
Investing Cash Flow | ||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||
Debt Issued | ||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||
Debt Repayment | ||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||
Equity Repurchased | ||||||||||||||
Dividend Paid | ||||||||||||||
Other Financing Activity | ||||||||||||||
Financing Cash Flow | ||||||||||||||
Cash Position | ||||||||||||||
Beginning Cash Position | ||||||||||||||
End Cash Position | ||||||||||||||
Change in Cash | ||||||||||||||
Free Cash Flow | ||||||||||||||
Operating Cash Flow | ||||||||||||||
Capital Expenditure | ||||||||||||||
Free Cash Flow |